BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
dr. lal path labs ltd. stock

DR. LAL PATH LABS LTD. Share Price

3153.45 -12.80 (-0.40%)
Dec 11 2024 03:30 PM Healthcare NSE: LALPATHLAB

DR. LAL PATH LABS LTD. Share Price Update

As of the latest trading session, DR. LAL PATH LABS LTD. share price is currently at 3153.45, which is down by -12.80 from its previous closing. Today, the stock has fluctuated between 3137.25 and 3179.20. Over the past year, DR. LAL PATH LABS LTD. has achieved a return of 23.59 %. In the last month alone, the return has been 5.19 %. Read More...

DR. LAL PATH LABS LTD. Performance

Day Range

Low3137.25 High3179.20
3153.45

52 Week Range

Low 1943.70 High 3653.95
3153.45

DR. LAL PATH LABS LTD. Share Price

11654

539524

LALPATHLAB

img img img img
No Data Available

Open Price

3170.25

Prev. Close

3166.25

Volume (Shares)

108145.00

Total traded value

3410.29

Upper Circuit

3482.85

Lower Circuit

2849.65

Note: The current prices & values are delayed, Login to your account for live updates.

DR. LAL PATH LABS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 26324.32
PE Ratio (TTM) 60.46
Book Value / Share 248.18
Beta 0.46
ROE 21.42%
EPS (TTM) 52.15
Dividend Yield 0.57%
Net Profit Qtr (Cr) 135.20

DR. LAL PATH LABS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 583.90
Operating Expense 422.60
Net Profit 135.20
Net Profit Margin (%) 23.15
Earnings Per Share (EPS) 16.24
EBITDA 206.50
Effective Tax Rate (%) 26.24
Particulars JUN 2024 (Values in Cr)
Revenue 534.50
Operating Expense 402.30
Net Profit 122.90
Net Profit Margin (%) 22.99
Earnings Per Share (EPS) 14.76
EBITDA 184.30
Effective Tax Rate (%) 23.66
Particulars MAR 2024 (Values in Cr)
Revenue 479.00
Operating Expense 374.40
Net Profit 89.50
Net Profit Margin (%) 18.68
Earnings Per Share (EPS) 10.73
EBITDA 146.20
Effective Tax Rate (%) 25.72
Particulars DEC 2023 (Values in Cr)
Revenue 476.00
Operating Expense 371.60
Net Profit 88.30
Net Profit Margin (%) 18.55
Earnings Per Share (EPS) 10.78
EBITDA 145.20
Effective Tax Rate (%) 26.10
Particulars SEP 2023 (Values in Cr)
Revenue 531.70
Operating Expense 394.90
Net Profit 113.00
Net Profit Margin (%) 21.25
Earnings Per Share (EPS) 13.60
EBITDA 177.10
Effective Tax Rate (%) 25.11
Particulars MAR 2024 (Values in Cr)
Revenue 1966.80
Operating Expense 1510.89
Net Profit 384.40
Net Profit Margin (%) 19.54
Earnings Per Share (EPS) 46.25
EBITDA 619.30
Effective Tax Rate (%) 25.50
Particulars MAR 2023 (Values in Cr)
Revenue 1769.00
Operating Expense 1424.80
Net Profit 292.40
Net Profit Margin (%) 16.52
Earnings Per Share (EPS) 35.28
EBITDA 507.29
Effective Tax Rate (%) 25.17
Particulars MAR 2022 (Values in Cr)
Revenue 1878.80
Operating Expense 1470.89
Net Profit 345.30
Net Profit Margin (%) 18.37
Earnings Per Share (EPS) 41.61
EBITDA 565.50
Effective Tax Rate (%) 25.09
Particulars MAR 2021 (Values in Cr)
Revenue 1490.50
Operating Expense 1167.70
Net Profit 280.10
Net Profit Margin (%) 18.79
Earnings Per Share (EPS) 33.93
EBITDA 458.70
Effective Tax Rate (%) 25.12
Particulars MAR 2020 (Values in Cr)
Revenue 1273.60
Operating Expense 1028.50
Net Profit 223.20
Net Profit Margin (%) 17.52
Earnings Per Share (EPS) 27.09
EBITDA 385.40
Effective Tax Rate (%) 26.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 221.53
ROE % 20.61
ROCE % 25.58
Total Debt to Total Equity 0.19
EBITDA Margin 30.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 199.87
ROE % 15.22
ROCE % 18.51
Total Debt to Total Equity 0.30
EBITDA Margin 26.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 180.17
ROE % 25.51
ROCE % 29.46
Total Debt to Total Equity 0.25
EBITDA Margin 29.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 149.39
ROE % 26.03
ROCE % 32.56
Total Debt to Total Equity 0.07
EBITDA Margin 30.84
Particulars MAR 2020 (Values in Cr)
Book Value / Share 126.81
ROE % 23.01
ROCE % 31.44
Total Debt to Total Equity 0.00
EBITDA Margin 29.96
Particulars MAR 2024 (Values in Cr)
Book Value / Share 227.56
ROE % 21.42
ROCE % 25.77
Total Debt to Total Equity 0.12
EBITDA Margin 31.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share 202.70
ROE % 18.49
ROCE % 20.93
Total Debt to Total Equity 0.21
EBITDA Margin 28.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 176.63
ROE % 25.68
ROCE % 29.35
Total Debt to Total Equity 0.16
EBITDA Margin 30.10
Particulars MAR 2021 (Values in Cr)
Book Value / Share 146.03
ROE % 25.08
ROCE % 31.55
Total Debt to Total Equity 0.02
EBITDA Margin 30.77
Particulars MAR 2020 (Values in Cr)
Book Value / Share 124.83
ROE % 22.92
ROCE % 31.14
Total Debt to Total Equity 0.00
EBITDA Margin 30.26
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 830.31
Total Assets 2455.96
Total Liabilities 2455.96
Total Equity 1885.36
Share Outstanding 83477852
Price to Book Ratio 9.94
Return on Assets (%) 14.56
Return on Capital (%) 18.17
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 665.41
Total Assets 2385.56
Total Liabilities 2385.56
Total Equity 1699.54
Share Outstanding 83367877
Price to Book Ratio 9.02
Return on Assets (%) 10.01
Return on Capital (%) 12.34
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 617.59
Total Assets 2346.75
Total Liabilities 2346.75
Total Equity 1537.06
Share Outstanding 83344877
Price to Book Ratio 14.76
Return on Assets (%) 14.69
Return on Capital (%) 18.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 926.02
Total Assets 1661.33
Total Liabilities 1661.33
Total Equity 1276.01
Share Outstanding 83344877
Price to Book Ratio 18.54
Return on Assets (%) 17.55
Return on Capital (%) 22.85
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 569.11
Total Assets 1374.30
Total Liabilities 1374.30
Total Equity 1054.02
Share Outstanding 83344877
Price to Book Ratio 11.23
Return on Assets (%) 16.44
Return on Capital (%) 21.44
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 683.11
Total Assets 2415.44
Total Liabilities 2415.44
Total Equity 1899.66
Share Outstanding 83477852
Price to Book Ratio 9.94
Return on Assets (%) 15.91
Return on Capital (%) 19.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 534.21
Total Assets 2320.17
Total Liabilities 2320.17
Total Equity 1689.86
Share Outstanding 83367877
Price to Book Ratio 9.02
Return on Assets (%) 12.60
Return on Capital (%) 15.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 542.90
Total Assets 2210.78
Total Liabilities 2210.78
Total Equity 1472.11
Share Outstanding 83344877
Price to Book Ratio 14.76
Return on Assets (%) 15.61
Return on Capital (%) 19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 888.63
Total Assets 1573.07
Total Liabilities 1573.07
Total Equity 1217.08
Share Outstanding 83344877
Price to Book Ratio 18.54
Return on Assets (%) 17.80
Return on Capital (%) 23.01
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 549.19
Total Assets 1317.93
Total Liabilities 1317.93
Total Equity 1016.28
Share Outstanding 83344877
Price to Book Ratio 11.23
Return on Assets (%) 16.93
Return on Capital (%) 21.96
Particulars MAR 2024 (Values in Cr)
Net Income 362.29
Cash from Operations 667.36
Cash from Investing -24.26
Cash from Financing -413.86
Net change in Cash 97.20
Free Cash Flow 718.53
Particulars MAR 2023 (Values in Cr)
Net Income 241.07
Cash from Operations 562.46
Cash from Investing -287.30
Cash from Financing -283.18
Net change in Cash -114.46
Free Cash Flow 598.97
Particulars MAR 2022 (Values in Cr)
Net Income 350.29
Cash from Operations 576.72
Cash from Investing -449.24
Cash from Financing 136.45
Net change in Cash 133.89
Free Cash Flow 670.82
Particulars MAR 2021 (Values in Cr)
Net Income 296.47
Cash from Operations 499.85
Cash from Investing -212.01
Cash from Financing -138.55
Net change in Cash 47.57
Free Cash Flow 535.41
Particulars MAR 2020 (Values in Cr)
Net Income 227.58
Cash from Operations 377.36
Cash from Investing -26.11
Cash from Financing -190.44
Net change in Cash 67.33
Free Cash Flow 424.49
Particulars MAR 2024 (Values in Cr)
Net Income 384.37
Cash from Operations 603.02
Cash from Investing 31.91
Cash from Financing -403.99
Net change in Cash 105.51
Free Cash Flow 647.91
Particulars MAR 2023 (Values in Cr)
Net Income 292.35
Cash from Operations 526.65
Cash from Investing -288.47
Cash from Financing -270.04
Net change in Cash -130.98
Free Cash Flow 558.36
Particulars MAR 2022 (Values in Cr)
Net Income 345.25
Cash from Operations 543.25
Cash from Investing -448.53
Cash from Financing 141.24
Net change in Cash 118.43
Free Cash Flow 606.34
Particulars MAR 2021 (Values in Cr)
Net Income 280.10
Cash from Operations 470.47
Cash from Investing -195.19
Cash from Financing -135.74
Net change in Cash 42.42
Free Cash Flow 498.52
Particulars MAR 2020 (Values in Cr)
Net Income 223.18
Cash from Operations 361.15
Cash from Investing -19.47
Cash from Financing -187.22
Net change in Cash 65.29
Free Cash Flow 404.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7256.20 88.19 13.92 104333.02 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.73 0.00 3.94 117.57 44.00 / 107.94
SHREE PACETRONIX LTD. 118.35 19.06 3.17 42.60 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.49 0.00 5.23 56.75 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7256.20 92.91 12.73 104333.02 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 56.18 0.00 -30.09 41.97 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5366.00 29.10 6.02 5870.40 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 3088.20
  • 26 Days 3052.70
  • 10 Days 3067.80
  • 50 Days 3126.70
  • 12 Days 3059.20
  • 100 Days 3149.90
  • 20 Days 3045.90
  • 200 Days 2567.30
3171.42
PIVOT
First Resistance 3201.83
Second Resistance 3237.42
Third Resistance 3267.83
First Support 3135.83
Second Support 3105.42
Third Support 3069.83
RSI 59.29
MACD 6.49
Commodity Channel Index (CCI) 229.16
ADX 12.40
Williams % R -15.92

Over 1 Month

down

5.19

Over 3 Months

down

-6.26

Over 6 Months

down

13.73

Over 1 Year

down

23.59

Over 3 Years

down

-3.30

Over 5 Years

down

15.56

DR. LAL PATH LABS LTD. Future

Future: Price

26 Dec
3164.10
30 Jan
3185.00
27 Feb
3186.55
25 May
0 100 200 300 400 500 600

Discount/Premium

26 Dec
10.65
30 Jan
31.55
27 Feb
33.10
25 May
0 1 2 3 4 5 6 7

Active Calls

3200.0
928
3300.0
654
3150.0
462
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

3100.0
275
3150.0
256
2900.0
225
25 Jul
0 500 1000 1500 2000 2500

DR. LAL PATH LABS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
6.36
Promoter Holdings
53.91
FII
26.82
DII
12.89
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Arvind Lal Shareholding of Promoter and Promoter Group 2.5745443E7 30.81
Vandana Lal Shareholding of Promoter and Promoter Group 1.6082327E7 19.24
Invesco Oppenheimer International Growth Fund Public Shareholding 2978635.0 3.56
Hdfc Trustee Company Limited-hdfc Flexi Cap Fund Public Shareholding 2756989.0 3.3
Uti Flexi Cap Fund Public Shareholding 1925594.0 2.3
Anjaneya Lal Shareholding of Promoter and Promoter Group 1689614.0 2.02
Archana Lal Erdmann Shareholding of Promoter and Promoter Group 1543751.0 1.85
Sbi Large & Midcap Fund Public Shareholding 1467251.0 1.76
Life Insurance Corporation Of India Public Shareholding 1231246.0 1.47
First Sentier Investors Icvc - Stewart Investors Indian Subcontinent Sustainability Fund Public Shareholding 921999.0 1.1
St. James's Place Emerging Markets Equity Unit Trust Managed By Wasatch Advisors Inc Public Shareholding 891279.0 1.07
Om Prakash Manchanda Public Shareholding 869000.0 1.04

DR. LAL PATH LABS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-13 12.0 Interim 2 2024-02-13 Equity shares 2023-08-11 6.0 Final 2023-08-11 Equity shares 2023-08-11 6.0 Interim 2023-08-11 Equity shares 2022-08-05 6.0 Interim 2022-08-09 Equity shares 2022-06-22 6.0 Final 2022-06-23 Equity shares 2021-08-18 6.0 Interim 2021-08-22 Equity shares 2021-07-20 8.0 Final 2021-07-22 Equity shares 2021-02-09 6.0 Interim 2 2021-02-10 Equity shares 2020-11-18 6.0 Interim 2020-11-19 Equity shares 2020-03-05 6.0 Interim 2 2020-03-06 Equity shares 2019-11-20 6.0 Interim 2019-11-21 Equity shares 2019-08-02 3.5 Final 2019-08-06 Equity shares 2018-11-19 2.5 Interim 2018-11-20 Equity shares 2018-08-03 3.0 Final 2018-08-07 Equity shares 2017-11-20 1.5 Interim 2017-11-21 Equity shares 2017-07-12 1.7 Final 2017-07-14 Equity shares 2017-02-13 1.3 Interim 2017-02-14 Equity shares 2016-07-20 2.45 Final 2016-07-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About DR. LAL PATH LABS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by DR. LAL PATH LABS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Dr Lal Pathlabs Ltd?

Answer Field

The share price of Dr Lal Pathlabs Ltd for NSE is ₹ 3153.45 and for BSE is ₹ 3153.1.

What is the Market Cap of Dr Lal Pathlabs Ltd?

Answer Field

The market cap of Dr Lal Pathlabs Ltd for NSE is ₹ 2,63,24.32 Cr. and for BSE is ₹ 2,63,21.40 Cr. as of now.

What is the 52 Week High and Low of Dr Lal Pathlabs Ltd?

Answer Field

The 52 Week High and Low of Dr Lal Pathlabs Ltd for NSE is ₹ 3653.95 and ₹ 1943.70 and for BSE is ₹ 3645.00 and ₹ 1943.20.

How to Buy Dr Lal Pathlabs Ltd share?

Answer Field

You can trade in Dr Lal Pathlabs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Dr Lal Pathlabs Ltd?

Answer Field

The 1 year returns on the stock has been 23.59%.

What is the Current Share Price of Dr Lal Pathlabs Ltd?

Answer Field

Dr Lal Pathlabs Ltd share price is for NSE ₹ 3153.45 & for BSE ₹ 3153.1 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Dr Lal Pathlabs Ltd Share?

Answer Field

The market cap of Dr Lal Pathlabs Ltd for NSE ₹ 2,63,24.32 & for BSE ₹ 2,63,21.40 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Dr Lal Pathlabs Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Dr Lal Pathlabs Ltd share is 60.46.

What is the PB ratio of Dr Lal Pathlabs Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Dr Lal Pathlabs Ltd share is 248.18.

How to Buy Dr Lal Pathlabs Ltd Share?

Answer Field

You can trade in Dr Lal Pathlabs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Lal Pathlabs Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Lal Pathlabs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Lal Pathlabs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader